全文获取类型
收费全文 | 2024篇 |
免费 | 129篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 69篇 |
妇产科学 | 39篇 |
基础医学 | 239篇 |
口腔科学 | 49篇 |
临床医学 | 200篇 |
内科学 | 449篇 |
皮肤病学 | 3篇 |
神经病学 | 164篇 |
特种医学 | 354篇 |
外科学 | 129篇 |
综合类 | 42篇 |
预防医学 | 178篇 |
眼科学 | 36篇 |
药学 | 142篇 |
中国医学 | 2篇 |
肿瘤学 | 76篇 |
出版年
2021年 | 25篇 |
2019年 | 15篇 |
2018年 | 26篇 |
2017年 | 23篇 |
2016年 | 22篇 |
2015年 | 26篇 |
2014年 | 38篇 |
2013年 | 57篇 |
2012年 | 64篇 |
2011年 | 82篇 |
2010年 | 60篇 |
2009年 | 50篇 |
2008年 | 84篇 |
2007年 | 79篇 |
2006年 | 62篇 |
2005年 | 48篇 |
2004年 | 47篇 |
2003年 | 50篇 |
2002年 | 53篇 |
2001年 | 55篇 |
2000年 | 53篇 |
1999年 | 46篇 |
1998年 | 58篇 |
1997年 | 48篇 |
1996年 | 73篇 |
1995年 | 57篇 |
1994年 | 46篇 |
1993年 | 45篇 |
1992年 | 32篇 |
1991年 | 34篇 |
1990年 | 37篇 |
1989年 | 50篇 |
1988年 | 56篇 |
1987年 | 47篇 |
1986年 | 52篇 |
1985年 | 54篇 |
1984年 | 39篇 |
1983年 | 42篇 |
1982年 | 36篇 |
1981年 | 32篇 |
1980年 | 18篇 |
1979年 | 13篇 |
1978年 | 16篇 |
1977年 | 30篇 |
1976年 | 28篇 |
1975年 | 21篇 |
1972年 | 13篇 |
1971年 | 12篇 |
1970年 | 12篇 |
1969年 | 16篇 |
排序方式: 共有2176条查询结果,搜索用时 31 毫秒
91.
鸟氨酸脱羧酶的生理病理特点及其药物研究概况 总被引:2,自引:0,他引:2
鸟氨酸脱羧酶(ornithinedecarboxylase,ODC)是多胺代谢中的关键酶,广泛存在于人体和动物各组织细胞内,其中对肠细胞的增生、移行和分化起重要作用.机体调节因素比较复杂.在黏膜损伤性疾病及某些癌前病变等细胞大量增生的病理情况下ODC的表达发生改变,可以作为这些疾病分期、预后及药物作用靶点或疗效的指标.寻找对ODC有作用的药物对于治疗其相关疾病是非常有意义的. 相似文献
92.
Nicole L. Stout DPT Justin C. Brown PhD Anna L. Schwartz PhD FNP Timothy F. Marshall PhD Anna M. Campbell PhD MBE Larissa Nekhlyudov MD MPH David S. Zucker MD PhD Karen M. Basen-Engquist PhD MPH Grace Campbell PhD MSW RN Jeffrey Meyerhardt MD MPH Andrea L. Cheville MD MSSE Kelley R. Covington MS Jennifer A. Ligibel MD Jonas M. Sokolof DO Kathryn H. Schmitz PhD MPH Catherine M. Alfano PhD 《Cancer》2020,126(12):2750-2758
93.
94.
Rea IM Mc Dowell I McMaster D Smye M Stout R Evans A;MONICA group 《Mechanisms of ageing and development》2001,122(13):1367-1372
The ApoE gene has three alleles coding for the proteins apoE2, apoE3 and apoE4. E4 has been reported to be associated with hypercholesteraemia, ischaemic heart disease, age-related cognitive decline and Alzheimer's disease. Conversely, the E2 allele has been associated with longevity in French centenarians and their siblings. In this study, we have assessed any shift in the ApoE genotypes in nonagenarian subjects from Belfast where there is a high intrinsic incidence of cardiovascular disease. ApoE phenotypes were determined by electrofocusing and immunoblotting in 114 Senieur-approximated subjects >90 years old and compared with 2071 subjects, 30--65 years of age, recruited from the same geographical area by the MONItoring of CArdiovascular trends study group in Belfast (MONICA). The E4 allele was reduced in the nonagenarian group (X(2)=11.1; P=0.0006), the E3 unchanged and E2 frequency was increased (X(2)=4.0; P=0.047). These results suggest that longevity is negatively associated with the E4 allele and may be associated with carriage of E2. 相似文献
95.
目的:分析血管紧张素原基因启动子区A-20C和A-6G单核苷酸多态性与蒙古族人群原发性高血压的相关性。方法:实验于2005-08/2006-01在北京华大实验室完成。选取对象均为生活在内蒙古乌拉特后旗的蒙古族牧民,三代血亲内无其他民族。采用基因测序技术对内蒙古蒙古族人群中107例原发性高血压患者和108例正常对照者进行A-20C和A-6G基因分型,观察高血压组和正常对照组不同基因型的分布和等位基因频率的差异。结果:①两组受试者在性别、年龄及吸烟、饮酒、体质量指数和临床化验检查指标有较好的匹配(P均>0.05)。②两组血管紧张素原基因A-20C位点AA,AC,CC基因型频率比较差异无显著性意义(高血压组分别为0.51,0.29,0.20;正常对照组分别为0.49,0.28,0.23,χ2=0.395,P=0.529)。A,C等位基因频率比较差异无显著性意义(高血压组分别为0.65,0.35;正常对照组分别为0.63,0.37,χ2=0.015,P=0.904)。③两组血管紧张素原基因A-6G位点AA,AG,GG基因型频率比较差异无显著性意义(高血压组分别为0.50,0.33,0.17;正常对照组分别为0.55,0.34,0.11,χ2=1.924,P=0.165)。A,G等位基因频率比较差异无显著性意义(高血压组分别为0.66,0.34;正常对照组分别为0.72,0.28,χ2=1.728,P=0.189)。④高血压组协同存在血管紧张素原基因A-20C基因型CC时,血管紧张素原基因A-6G基因型GG频率稍高于正常对照组,但差异无显著性意义(χ2=2.395,P=0.122,OR=7.52,95%CI0.014~1.250),高血压组G等位基因明显高于正常对照组(分别为0.37,0.22,χ2=4.658,P=0.034),携带该等位基因的蒙古族人群发生原发性高血压的相对危险度升高(OR=2.80,95%CI1.087~7.271)。结论:血管紧张素原基因A-20C和A-6G单核苷酸多态性与蒙古族人群原发性高血压相关,并可能具有协同作用。 相似文献
96.
97.
Friedmann PD Rose JS Swift R Stout RL Millman RP Stein MD 《Alcoholism, clinical and experimental research》2008,32(9):1652-1660
Background: Trazodone is a commonly prescribed off-label for sleep disturbance in alcohol-dependent patients, but its safety and efficacy for this indication is unknown.
Methods: We conducted a randomized, double-blind, placebo-control trial of low-dose trazodone (50 to 150 mg at bedtime) for 12 weeks among 173 alcohol detoxification patients who reported current sleep disturbance on a validated measure of sleep quality or during prior periods of abstinence. Primary outcomes were the proportion of days abstinent and drinks per drinking day over 6-months; sleep quality was also assessed.
Results: Urn randomization balanced baseline features among the 88 subjects who received trazodone and 85 who received placebo. The trazodone group experienced less improvement in the proportion of days abstinent during administration of study medication (mean change between baseline and 3 months: −0.12; 95% CI: −0.15 to −0.09), and an increase in the number of drinks per drinking day on cessation of the study medication (mean change between baseline and 6 months, 4.6; 95% CI: 2.1 to 7.1). Trazodone was associated with improved sleep quality during its administration (mean change on the Pittsburgh Sleep Quality Index between baseline and 3 months: −3.02; 95% CI: −3.38 to −2.67), but after it was stopped sleep quality equalized with placebo.
Conclusions: Trazodone, despite a short-term benefit on sleep quality, might impede improvements in alcohol consumption in the postdetoxification period and lead to increased drinking when stopped. Until further studies have established benefits and safety, routine initiation of trazodone for sleep disturbance cannot be recommended with confidence during the period after detoxification from alcoholism. 相似文献
Methods: We conducted a randomized, double-blind, placebo-control trial of low-dose trazodone (50 to 150 mg at bedtime) for 12 weeks among 173 alcohol detoxification patients who reported current sleep disturbance on a validated measure of sleep quality or during prior periods of abstinence. Primary outcomes were the proportion of days abstinent and drinks per drinking day over 6-months; sleep quality was also assessed.
Results: Urn randomization balanced baseline features among the 88 subjects who received trazodone and 85 who received placebo. The trazodone group experienced less improvement in the proportion of days abstinent during administration of study medication (mean change between baseline and 3 months: −0.12; 95% CI: −0.15 to −0.09), and an increase in the number of drinks per drinking day on cessation of the study medication (mean change between baseline and 6 months, 4.6; 95% CI: 2.1 to 7.1). Trazodone was associated with improved sleep quality during its administration (mean change on the Pittsburgh Sleep Quality Index between baseline and 3 months: −3.02; 95% CI: −3.38 to −2.67), but after it was stopped sleep quality equalized with placebo.
Conclusions: Trazodone, despite a short-term benefit on sleep quality, might impede improvements in alcohol consumption in the postdetoxification period and lead to increased drinking when stopped. Until further studies have established benefits and safety, routine initiation of trazodone for sleep disturbance cannot be recommended with confidence during the period after detoxification from alcoholism. 相似文献
98.
99.
100.
Chris Suckow Claudia Kuntner Patrick Chow Robert Silverman Arion Chatziioannou David Stout 《Molecular imaging and biology》2009,11(2):100-106
Purpose The ability to reproducibly and repeatedly image rodents in noninvasive imaging systems, such as small-animal positron emission
tomography (PET) and computed tomography (CT), requires a reliable method for anesthetizing, positioning, and heating animals
in a simple reproducible manner. In this paper, we demonstrate that mice and rats can be reproducibly and repeatedly imaged
using an imaging chamber designed to be rigidly mounted on multiple imaging systems.
Procedures Mouse and rat imaging chambers were made of acrylic plastic and aluminum. MicroCT scans were used to evaluate the positioning
reproducibility of the chambers in multimodality and longitudinal imaging studies. The ability of the chambers to maintain
mouse and rat body temperatures while anesthetized with gas anesthesia was also evaluated.
Results Both the mouse and rat imaging chambers were able to reproducibly position the animals in the imaging systems with a small
degree of error. Placement of the mouse in the mouse imaging chamber resulted in a mean distance of 0.23 mm per reference
point in multimodality studies, whereas for longitudinal studies the mean difference was 1.11 mm. The rat chamber resulted
in a mean difference of 0.46 mm in multimodality studies and a mean difference of 4.31 mm in longitudinal studies per reference
point. The chambers maintained rodent body temperatures at the set point temperature of 38°C.
Conclusions The rodent imaging chambers were able to reproducibly position rodents in tomographs with a small degree of variability and
were compatible with routine use. The embedded anesthetic line and heating system was capable of maintaining the rodent’s
temperature and anesthetic state, thereby enhancing rodent health and improving data collection reliability. 相似文献